New York Times: What to expect when a coronavirus vaccine arrives
Audiences are reliving contributions by UC's Albert Sabin as part of historical vaccine talk
An article in today’s New York Times discusses the contributions of UC’s famed doctor Albert Sabin, who developed the live oral polio vaccine.
In 1958, “the federal government approved an oral polio vaccine, developed by Sabin’s laboratory in Cincinnati, containing weakened, not inactivated, virus,” states the article. “By the end of that year, polio infections were down 90 percent from 1955 levels. In 1979, the country recorded its last community-transmitted case.
"Today, decades into a global vaccination campaign, polio persists in just three countries. The battle against the disease has been a century-long march. And it has required a sustained commitment to continuing polio vaccination — a commitment now compromised as global polio vaccination efforts have been put on hold to slow the coronavirus’s spread."
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.